Sumitomo Mitsui Trust Holdings, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$62.15 - $90.32 $11.4 Million - $16.5 Million	-182,704 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$61.35 - $90.47 $1.47 Million - $2.17 Million	23,973 Added 15.1%	182,704 $12.1 Million
Q4 2020 Feb 05, 2021	BUY	$43.82 - $85.37 $6.96 Million - $13.6 Million	158,731 New	158,731 $12.2 Million

302

95.7M

523K

493K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.46B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.